- Trials with a EudraCT protocol (49)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
49 result(s) found for: Family medicine.
Displaying page 1 of 3.
| EudraCT Number: 2008-006795-30 | Sponsor Protocol Number: Satauni | Start Date*: 2009-01-16 | |||||||||||
| Sponsor Name:Institute of Clinical Medicine, Family Medicine, University of Turku | |||||||||||||
| Full Title: Controlled-release melatonin in fast withdrawal of temazepam, zopiclone or zolpidem in elderly persons with insomnia | |||||||||||||
| Medical condition: Individuals over 55 years with primary insomnia and DDD need of temazepam, zopiclone or zolpidem | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: FI (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2008-006135-12 | Sponsor Protocol Number: BalaCriCo | Start Date*: 2008-12-19 |
| Sponsor Name:Charité- University Medicine Berlin | ||
| Full Title: Balanced crystalloids versus balanced colloids within a goal-directed hemodynamic protocol in patients undergoing gynaecological tumor resection. Balancierte Kristalloide versus balancierte Kolloi... | ||
| Medical condition: The drugs Jonsteril and Volulyte6% will be investigated in female patients undergoing a tumor reduction operation. The study population will be female patients with metastatic ovarian carcinoma. Th... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Female | |
| Trial protocol: DE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2005-004013-15 | Sponsor Protocol Number: 920'110 | Start Date*: 2006-01-11 |
| Sponsor Name:Bioforce AG | ||
| Full Title: Effects of Echinaforce®-treatment on the response of ex vivo stimulated blood cells | ||
| Medical condition: Healthy volunteers | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2022-000240-30 | Sponsor Protocol Number: 80308 | Start Date*: 2022-04-19 |
| Sponsor Name:Center for Experimental and Molecular Medicine, G2 (AMC) | ||
| Full Title: The chemopreventive effect of Lithium on adenoma development in patients with familial adenomatous polyposis (FAP); a pilot study | ||
| Medical condition: Familial adenomatous polyposis | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2004-002020-17 | Sponsor Protocol Number: 10908458 | Start Date*: 2005-02-23 |
| Sponsor Name:Catalan Society of Family Medicine, represented by Dr Mariano de la Figuera Von Wichman and Gabriel | ||
| Full Title: ESTRATEGIAS PARA EL TRATAMIENTO DE LA HIPERTENSIÓN ARTERIAL. EVALUACIÓN DE UNA TERAPIA COMBINADA A DOSIS FIJAS (LOSARTÁN/HIDROCLOROTIAZIDA) vs MONOTERAPIA (ESTRATAAR). (STRATEGIES FOR THE TREATMENT... | ||
| Medical condition: Stage II arterial Hypertension | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2014-001314-25 | Sponsor Protocol Number: KIANANDR140701 | Start Date*: 2015-03-10 |
| Sponsor Name:Karolinska Institutet | ||
| Full Title: The effect of on demand versus continuous use of proton pump inhibitors on reflux symptoms, quality of life and self-rated health in patients with gastro-oesophageal reflux disease | ||
| Medical condition: Gastrooesophageal reflux disease | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: View results | ||
| EudraCT Number: 2023-000824-12 | Sponsor Protocol Number: B7981031 | Start Date*: 2023-09-06 |
| Sponsor Name:Pfizer, Inc. | ||
| Full Title: AN INTERVENTIONAL PK, PD, PHASE 1, OPEN-LABEL STUDY TO INVESTIGATE PK AND PD OF MULTIPLE-DOSE RITLECITINIB IN CHILDREN 6 TO LESS THAN 12 YEARS OF AGE WITH SEVERE ALOPECIA AREATA | ||
| Medical condition: Alopecia Areata | ||
| Disease: | ||
| Population Age: Children, Under 18 | Gender: Male, Female | |
| Trial protocol: Outside EU/EEA | ||
| Trial results: View results | ||
| EudraCT Number: 2009-016043-19 | Sponsor Protocol Number: HIPSTER | Start Date*: 2010-04-12 |
| Sponsor Name:Charité – University Medicine Berlin | ||
| Full Title: Impact of a balanced infusion solution compound of 50% cristalloid and 50% colloid versus a unbalanced infusion solution of 100% cristalloid within a goal-directed hemodynamic protocol on acid-base... | ||
| Medical condition: Patients undergoing elective hip replacement surgery will be divided into two groups. In one group an intravenous application of Ringer Baxter Infusionsloesung, in the other group a parallel intra... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2021-006223-18 | Sponsor Protocol Number: PXL-770-011 | Start Date*: 2022-05-03 |
| Sponsor Name:Poxel S.A. | ||
| Full Title: A randomized open-label Phase 2a study to assess the pharmacokinetics and pharmacodynamic parameters of PXL770 after 12 weeks of treatment in male subjects with adrenomyeloneuropathy (AMN) | ||
| Medical condition: Adrenomyeloneuropathy (AMN) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male | |
| Trial protocol: DE (Prematurely Ended) NL (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-003971-16 | Sponsor Protocol Number: FEMODRIC | Start Date*: 2021-06-07 |
| Sponsor Name:Fundació Assistencial Mútua Terrassa | ||
| Full Title: A randomised, double-blind, comparative clinical trial of the effectiveness and tolerability of fentanyl in continuous parenteral perfusion versus on-demand bolus of morphine for the treatment of ... | ||
| Medical condition: Refractory dyspnoea in patients hospitalised for acute decompensation of heart failure | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2017-003088-36 | Sponsor Protocol Number: GPPAD-03-POInT | Start Date*: 2018-01-30 | |||||||||||
| Sponsor Name:Technische Universität München, Represented by the school of medicine | |||||||||||||
| Full Title: GPPAD-POInT (Global Platform of Autoimmune Diabetes – Primary Oral Insulin Trial) Oral Insulin Therapy for Prevention of Autoimmune Diabetes | |||||||||||||
| Medical condition: risk for type 1 diabetes | |||||||||||||
|
|||||||||||||
| Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: SE (Completed) GB (GB - no longer in EU/EEA) PL (Completed) DE (Completed) BE (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2017-000632-34 | Sponsor Protocol Number: AAUH-ICU-01 | Start Date*: 2017-04-25 | ||||||||||||||||
| Sponsor Name:Department of Anaesthesia and Intensive Care Medicine, Aalborg University Hospital | ||||||||||||||||||
| Full Title: Handling oxygenation targets in adults with acute hypoxaemic respiratory failure in the intensive care unit: A randomised clinical trial of a lower versus a higher oxygenation target Addendum: Tri... | ||||||||||||||||||
| Medical condition: Acute hypoxaemic respiratory failure in patients admitted to the intensive care unit Addendum: Acute hypoxaemic respiratory failure in patients admitted to the intensive care unit with COVID-19 | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: DK (Prematurely Ended) FI (Completed) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2019-003720-20 | Sponsor Protocol Number: WI231434 | Start Date*: 2019-10-16 |
| Sponsor Name:University of Zagreb School of Medicine | ||
| Full Title: Varenicline Versus Cytisine for Smoking Cessation in the Primary Care Setting in Croatia and Slovenia - a Randomized Controlled Trial | ||
| Medical condition: Tobacco addiction | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: SI (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2010-022221-15 | Sponsor Protocol Number: PM104-B-003-10 | Start Date*: Information not available in EudraCT | ||||||||||||||||||||||||||
| Sponsor Name:Pharma Mar S.A., Sociedad Unipersonal | ||||||||||||||||||||||||||||
| Full Title: Phase II Multicenter, Open-label, Clinical and Pharmacokinetic Study of Zalypsis® (PM00104) in Patients with Unresectable Locally Advanced and/or Metastatic Ewing Family of Tumors (EFT) Progressing... | ||||||||||||||||||||||||||||
| Medical condition: Advanced and/or Metastatic Ewing Family of Tumors (EFT) | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
| Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
| Trial protocol: FR (Ongoing) IT (Completed) | ||||||||||||||||||||||||||||
| Trial results: View results | ||||||||||||||||||||||||||||
| EudraCT Number: 2005-001621-29 | Sponsor Protocol Number: 80804002 | Start Date*: 2009-05-05 |
| Sponsor Name:Faculty of Medicine Carl Gustav Carus, University of Technology, Dresden | ||
| Full Title: Pre-POINT (Primary Oral INsulin Trial) study A dose finding safety and immune efficacy study for primary mucosal insulin therapy in islet autoantibody negative children at high genetic risk for ty... | ||
| Medical condition: pre-type 1 diabetes (islet autoimmunity in non-diabetic relatives of subjects with type 1 diabetes) | ||
| Disease: | ||
| Population Age: Children, Under 18 | Gender: Male, Female | |
| Trial protocol: DE (Completed) AT (Completed) GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2019-003772-39 | Sponsor Protocol Number: DEMAND-pilot | Start Date*: 2019-12-13 |
| Sponsor Name:Umeå University | ||
| Full Title: Diet, physical exercise, and metabolic control intervention to reduce the incidence of major neurocognitive disorders among individuals with type 2 diabetes combined with mild neurocognitive impair... | ||
| Medical condition: Type 2 diabetes | ||
| Disease: | ||
| Population Age: Elderly | Gender: Male, Female | |
| Trial protocol: SE (Ongoing) | ||
| Trial results: View results | ||
| EudraCT Number: 2012-003480-21 | Sponsor Protocol Number: ClinDiab-03 | Start Date*: 2012-11-05 |
| Sponsor Name:Medizinische Universität Graz, Universitätsklinik für Innere Medizin, Klin. Abt. für Endokrinologie und Stoffwechsel | ||
| Full Title: An open, single-centre, non-controlled feasibility study on the performance of a tablet based workflow and decision support system with incorporated software algorithm used for glycaemic management... | ||
| Medical condition: Diabetes mellitus type 2 | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: AT (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2012-001335-31 | Sponsor Protocol Number: virus-specific_CD8_T-cells_001 | Start Date*: 2013-11-08 |
| Sponsor Name:Univerzita Karlova v Praze, 2. lékařská fakulta | ||
| Full Title: Adoptive transfer of CMV specific CD8+ T-cells to treat CMV infection after transplantation | ||
| Medical condition: chronic CMV infection after allogeneic hematopoietic stem cell transplantation in children, refractory to conventional antiviral treatment | ||
| Disease: | ||
| Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: CZ (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2005-003492-20 | Sponsor Protocol Number: MO05/7289 | Start Date*: 2006-09-18 |
| Sponsor Name:University of Leeds | ||
| Full Title: A randomised clinical trial of treatment for fluorouracil-resistant advanced colorectal cancer comparing standard single-agent irinotecan versus irinotecan plus panitumumab and versus irinotecan pl... | ||
| Medical condition: Fluorouracil-resistant advanced colorectal cancer | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: Removed from public view | ||
| EudraCT Number: 2011-004670-28 | Sponsor Protocol Number: 2011-AKA | Start Date*: 2012-04-25 | |||||||||||
| Sponsor Name:Aarhus University Hospital, Dept of Endocrinology and Internel Medicine (MEA) | |||||||||||||
| Full Title: Treatment of osteopenia with melatonin: Effects on BMD, muscle strength and quality of life | |||||||||||||
| Medical condition: Osteoporosis | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Female | ||||||||||||
| Trial protocol: DK (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
